U.S. SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549


                                   FORM 10-QSB


             QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
                         SECURITIES EXCHANGE ACT OF 1934

               For the quarterly period ended: September 30, 2000


                         Commission file number: 0-28154



                             SMLX TECHNOLOGIES, INC.
--------------------------------------------------------------------------------
        (Exact name of small business issuer as specified in its Charter)


                Colorado                                    84-1337509
----------------------------------                    ------------------------
(State or other jurisdiction of                       (I.R.S. Employer
incorporation or organization)                        Identification No.)


                 376 Ansin Boulevard, Hallandale, Florida 33009
 -----------------------------------------------------------------------------
           (Address of principal executive offices including zip code)


                                 (954) 455-0110
                     -------------------------------------
                           (Issuer's telephone number)


Indicate by check mark whether the Issuer (1) has filed all reports  required to
be filed by Section 13 or 15 (d) of the  Exchange  Act during the past 12 months
(or for such  shorter  period  that the  registrant  was  required  to file such
reports),  and (2) has been subject to such filing  requirements for the past 90
days.

                                 Yes [X] No [ ]

There  were  [____________________]  shares  of the  Registrant's  Common  Stock
outstanding as of [____________________], 2000.


<PAGE>



                     SMLX TECHNOLOGIES, INC. AND SUBSIDIARY
                           CONSOLIDATED BALANCE SHEETS
                                   (UNAUDITED)

<TABLE>
<CAPTION>
                                                                               9/30/2000                12/31/1999
                                                                            ----------------         -----------------
<S>                                                                       <C>                      <C>
ASSETS

CURRENT ASSETS
     Cash                                                                   $        78,854          $        215,026
     Accounts Receivable (Net of allowance for
         uncollectible accounts of $2,786 for 9/30/00 and
         12/31/99)                                                                      131                     6,071
     Inventory                                                                      176,541                   129,398
     Prepaid Expenses                                                                49,152                    23,299
                                                                            ----------------         -----------------
         Total Current Assets                                                       304,678                   373,794
                                                                            ----------------         -----------------

Property, Plant and Equipment, at cost (Net of
         accumulated depreciation and amortization of
         $265,295 and $197,336 on 09/30/00 and 12/31/99,
         respectively)                                                              365,309                   418,547

OTHER ASSETS
     Deposits                                                                         8,092                     8,192
     Other Intangible Assets (Net of accumulated
         amortization of $1,590 and $1,076 on 9/30/00 and
         12/31/99, respectively)                                                          -                       814
     Patents and Trademarks
         (Net of accumulated amortization of $1,621 and $969 on
         9/30/00 and 12/31/99, respectively)                                        131,649                    88,309
     Investment in Common Stock                                                     200,000                   200,000
     Employee Advances                                                                  100                         -
     Other Assets                                                                       300                         -
                                                                            ----------------         -----------------
Total Assets                                                                $     1,010,128          $      1,089,656
                                                                            ================         =================
</TABLE>




                   The accompanying notes are an integral part
                  of these consolidated financial statements.


                                       2

<PAGE>


                     SMLX TECHNOLOGIES, INC. AND SUBSIDIARY
                           CONSOLIDATED BALANCE SHEETS
                                   (UNAUDITED)

<TABLE>
<CAPTION>
                                                                               9/30/2000                12/31/1999
                                                                            ----------------         -----------------

<S>                                                                       <C>                       <C>
LIABILITIES AND STOCKHOLDERS' EQUITY

CURRENT LIABILITIES
     Accounts Payable and Accrued Liabilities                               $       207,412          $        190,164
     Current Portion of Notes Payable                                                16,913                    16,913
     Customer Deposits                                                               28,816                   180,841
                                                                            ----------------         -----------------
         Total Current Liabilities                                                  253,141                   387,918
                                                                            ----------------         -----------------
LONG-TERM DEBT
     Notes Payables, Net of Current Portion                                         309,205                   310,636

COMMITMENTS AND CONTINGENCIES

STOCKHOLDERS' EQUITY
     Common Stock (Par Value $.0001, Authorized
         100,000,000 Shares, Issued and Outstanding
         12,004,648 Shares on 9/30/00 and 11,544,648 on
         12/31/99)                                                                    1,200                     1,154
     Preferred Stock (Par Value $.0001, Authorized
         10,000,000 Shares, No Shares Issued and
         Outstanding)                                                                     -                         -
     Additional Paid-In Capital                                                   2,450,477                 2,450,516
     Deficit Accumulated                                                         (2,003,895)               (2,060,568)
                                                                            ----------------         -----------------
         Total Stockholders' Equity                                                 447,782                   391,102
                                                                            ----------------         -----------------
     Total Liabilities and Stockholders' Equity                             $     1,010,128          $      1,089,656
                                                                            ================         =================
</TABLE>




                   The accompanying notes are an integral part
                  of these consolidated financial statements.


                                       3

<PAGE>


                     SMLX TECHNOLOGIES, INC. AND SUBSIDIARY
                      CONSOLIDATED STATEMENT OF OPERATIONS
                                   (UNAUDITED)

<TABLE>
<CAPTION>
                                                                NINE MONTHS ENDED                    THREE MONTHS ENDED
                                                           9/30/2000           9/30/1999         9/30/2000         9/30/1999
                                                        ---------------     --------------     -------------    ---------------
<S>                                                   <C>                 <C>                 <C>              <C>
REVENUES - NET                                          $    1,311,666      $     810,874      $    349,071     $      404,502

COST OF GOODS SOLD                                             195,500             27,742            52,073              2,236
                                                        ---------------     --------------     -------------    ---------------

GROSS PROFIT                                                 1,116,166            783,132           296,998            402,266

OPERATING EXPENSES
     SELLING, GENERAL AND ADMINISTRATIVE EXPENSES              966,648            832,769           404,983            317,441
     DEPRECIATION AND AMORTIZATION EXPENSE                      69,654             44,661            22,866             14,697

         TOTAL OPERATING EXPENSES                            1,036,302            877,430           427,849            332,138

OPERATING PROFIT (LOSS)                                         79,864           (94,298)         (130,851)             70,128

INTEREST EXPENSE                                              (23,221)           (27,393)           (7,800)            (7,440)
                                                        ---------------     --------------     -------------    ---------------

NET PROFIT (LOSS)                                               56,643          (121,691)         (138,651)             62,688

NET (LOSS) PER SHARE                                             0.005            (0.010)           (0.011)              0.005

WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING               12,004,648         11,544,648        12,004,648         11,544,648
</TABLE>




                   The accompanying notes are an integral part
                  of these consolidated financial statements.


                                       4

<PAGE>



                     SMLX TECHNOLOGIES, INC. AND SUBSIDIARY
                      CONSOLIDATED STATEMENTS OF CASH FLOWS
                                   (UNAUDITED)

<TABLE>
<CAPTION>
                                                                                        NINE MONTHS ENDED
                                                                               9/30/2000                 9/30/1999
                                                                            ----------------         -----------------
<S>                                                                       <C>                       <C>
CASH FLOWS FROM OPERATING ACTIVITIES:
     Net Profit (Loss)                                                      $       56,643           $      (121,691)

     Adjustment to Reconcile Net (Loss) to Net Cash
         Provided By (Used in) Operating Activities:

     Depreciation and Amortization                                                  69,654                    44,661

     Changes in Operating Assets and Liabilities:
         Accounts Receivable                                                         5,940                    (7,479)
         Inventory                                                                 (47,143)                   (2,986)
         Deposits                                                                      100                         -
         Accounts Payable and Accrued Liabilities                                   17,248                   (38,304)
         Customer Deposits                                                        (152,025)                   72,018
         Prepaid Expenses and Organization Expenses                                (25,853)                  (23,777)
                                                                            ----------------         -----------------

     Net Cash (Used In) Provided By Operating Activities                           (75,436)                  (77,558)
                                                                            ----------------         -----------------

CASH FLOWS FROM INVESTING ACTIVITIES:
     Acquisition of Fixed Assets                                                   (20,724)                  (58,898)
     Patent Costs                                                                  (38,581)                   (8,186)
                                                                            ----------------         -----------------

     Net Cash Provided by (Used In) Investing Activities                           (59,305)                  (67,084)
                                                                            ----------------         -----------------

CASH FLOWS FROM FINANCING ACTIVITIES:
     Proceeds from Private Placement                                                     -                   619,903
     Proceeds from Notes Payable                                                    (1,431)                 (128,912)
                                                                            ----------------         -----------------

Net Cash Provided By (Used In) Financing Activities                                 (1,431)                  490,991
                                                                            ----------------         -----------------

Net Increase (Decrease) in Cash                                                   (136,172)                  346,349

Cash - Beginning of Period                                                         215,026                    47,594
                                                                            ----------------         -----------------

Cash - End of Period                                                        $       78,854           $       393,943
                                                                            ================         =================
</TABLE>


                   The accompanying notes are an integral part
                   of these consolidated financial statements.


                                       5

<PAGE>


                     SMLX TECHNOLOGIES, INC. AND SUBSIDIARY
                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
                               SEPTEMBER 30, 2000
                                   (UNAUDITED)

NOTE 1 - BASIS OF PRESENTATION

The   accompanying   unaudited   consolidated   financial   statements  of  SMLX
Technologies,  Inc. (the "Company") and its wholly-owned  subsidiaries,  Simplex
Medical Systems,  Inc. (a Florida  corporation) and Analyte  Diagnostics,  Inc.,
have been prepared in accordance with the  instructions and requirements of Form
10-QSB and,  therefore,  do not include all information and footnotes  necessary
for a fair presentation of financial position,  results of operations,  and cash
flows in  conformity  with  generally  accepted  accounting  principles.  In the
opinion  of  management,  such  financial  statements  reflect  all  adjustments
(consisting only of normal recurring accruals) necessary for a fair presentation
of the results of  operations  and  financial  position for the interim  periods
presented.  Operating  results  for the  interim  periods  are  not  necessarily
indicative  of the  results  that  may be  expected  for the  full  year.  These
financial  statements  should be read in conjunction  with the Company's  annual
report of Form 10-KSB.

These financial  statements give effect to the March 5, 1997 reverse acquisition
whereby Music Tones Ltd. (name subsequently  changed to Simplex Medical Systems,
Inc.) acquired all of the outstanding  common stock of Simplex Medical  Systems,
Inc. as if the transaction occurred on September 15, 1995.

NOTE 2 - BASIS OF PRESENTATION AND CONTINUED EXISTENCE

The  accompanying  financial  statements  have been  prepared  assuming that the
Company  will  continue as a going  concern.  Since  inception,  the Company has
experienced losses aggregating $2,003,895 and has been dependent upon loans from
stockholders  and other third  parties in order to satisfy  operations  to date.
Management  believes  that funds  generated  from  operations  will  provide the
Company  with  sufficient  cash flow  resources  to fund the  operations  of the
Company.  The financial statements do not include any adjustments to reflect the
possible future effects on the  recoverability  and  classification of assets or
the amounts and  classification of liabilities that may result from the possible
inability of the Company to continue as a going concern.

NOTE 3 - INVENTORY

Inventory consists of $176,541 of finished goods as of September 30, 2000.

NOTE 4 - PROPERTY, PLANT AND EQUIPMENT

Property, plant and equipment consists of the following at September 30, 2000:


                                       6

<PAGE>


         Leasehold Improvements                               $        188,806
         Office Furniture and Equipment                                 66,995
         Lab Equipment                                                 374,803
                                                              -----------------

         Total Equipment                                               630,604
              Less:  Accumulated Depreciation                          265,295
                                                                 --------------

         Total Property, Plant and Equipment                  $        365,309
                                                              =================


NOTE 5 - NOTES PAYABLE

         Interest Expense for the period ended
         September 30, 2000, amounted to:                     $       23,221

         Interest Expense for the period ended
         September 30, 1999, amounted to:                     $       27,393

NOTE 6 - INCOME TAXES

To date the  Company  has  incurred  tax  operating  losses  and  therefore  has
generated no income tax  liabilities.  As of September 30, 2000, the Company has
generated net operating  loss carry  forwards  totaling  $(2,003,895)  which are
available to offset future  taxable  income,  if any,  through the year 2011. As
utilization  of such an  operating  loss for tax  purposes is not  assured,  the
deferred  tax  asset has been  fully  reserved  through  the  recording  of 100%
valuation allowance.

The  components  of the net deferred  tax asset are as follows at September  30,
2000:

        Deferred Tax Assets:
             Net Operating Loss Carry forward               681,324

             Valuation Allowance                           (681,324)

NOTE 7 - CONCENTRATIONS

During the nine  months  ended  September  30,  2000,  revenue of  approximately
$976,000 was earned from a single customer,  Vector Medical  Technologies,  Inc.
This represents approximately 74% of the Company's year to date revenue.

NOTE 8 - CHANGES IN SECURITIES

During the quarter  ended,  March 31, 2000, the Company issued 460,000 shares of
its Common Stock which were not registered under the Securities and Exchange Act
of 1933,  as  amended.  The shares  were  issued  pursuant to a writ of mandamus
issued by the Circuit Court of Miami-


                                       7

<PAGE>


Dade County in connection with a lawsuit filed against the Company by John Faro.
The shares  are being  held in escrow  pending a  resolution  of various  claims
against Mr. Faro.

NOTE 9 - SUBSEQUENT EVENTS

On October 7, 2000, the Company announced the resignation of their president and
director James Whidden and cancellation of his option agreement. Mr. Whidden has
returned to Vector Medical Technologies, Inc., his previous employer and a major
customer of SMLX. The Company also announced that Colin Jones,  former president
of the Company who retired this year,  has resigned  from the Board.  Kenneth H.
Robertson,  a Board member,  was elected  president,  as was Gerald M. Wochna, a
Board member,  to vice  president  and general  counsel.  Mr.  Robertson and Mr.
Wochna joined the Company from  Robertson & Partners LLC, a private  equity firm
that through two of its funds invested $1,200,000 in SMLX in the summer and fall
of 1998.

The Company is in the middle of a government  investigation  concerning a former
product  of the  Company,  a Rapid  HIV Test  Kit,  and  whether  the Kits  were
manufactured  in accordance with good  manufacturing  practices and received FDA
approvals  and  clearances.  The new  officers  felt that because of the pending
litigation and the size of their  investment  that it was time to take an active
role in the Company and they and the Company  plan to fully  cooperate  with the
government  and  work  toward  a  settlement  of this  investigation  as well as
settling other pending company litigation.


                                       8

<PAGE>


ITEM 2.   MANAGEMENT'S  DISCUSSION  AND  ANALYSIS OF  FINANCIAL  CONDITIONS  AND
          RESULTS OF OPERATIONS.

     This Report  contains  forward-looking  statements that involve a number of
risks and uncertainties.  While these statements represent the Company's current
judgement in the future direction of the business,  such risks and uncertainties
could cause  actual  results to differ  materially  from any future  performance
suggested herein.  Certain factors that could cause results to differ materially
from those projected in the forward-looking  statements include timing of orders
and  shipments,  market  acceptance  of products,  ability to increase  level of
production,  impact of  government  requisitions,  availability  of  capital  to
finance growth and general economic conditions.

     The following  should be read in  conjunction  with the attached  Financial
Statements and Notes thereto of the Company.

RESULTS OF OPERATIONS

     THREE MONTHS ENDED  SEPTEMBER 30, 2000 VERSUS THREE MONTHS ENDED  SEPTEMBER
30, 1999

     During the three months ended  September 30, 2000, the Company had $349,071
in revenue compared to $404,502 in revenue during the  corresponding  prior year
period. The decrease in revenue was the result of reduced revenues from sales of
approximately $55,431 during 2000.

     Expenses for the three  months ended  September  30, 2000,  were  increased
approximately  $17,542  over  the  corresponding  prior  year  period  due to an
increase in legal expenses.

     NINE MONTHS ENDED SEPTEMBER 30, 2000 VERSUS NINE MONTHS ENDED SEPTEMBER 30,
1999

     During the nine months ended September 30, 2000, the Company had $1,311,666
in revenue compared to $810,874 in revenue during the  corresponding  prior year
period.  The  increase  in  revenue  was the  result of sales of  airbrators  of
$284,000  (all of which  occurred  during the quarter  ended March 31, 2000) and
increased revenues from Vector Medical of approximately $216,792 during 2000.

     Expenses for the nine months ended  September 30, 2000,  were  increased by
approximately  $133,279  over the same period for the  corresponding  prior year
period due to an increase in legal expenses.


                                       9

<PAGE>


LIQUIDITY AND CAPITAL RESOURCES

     As of September 30, 2000, the Company had working capital of  approximately
$51,537 compared to  approximately  $(14,241) at December 31, 1999. The increase
is due to the net income for the nine months.

     As of  September  30,  2000,  the Company had no material  commitments  for
capital expenditures.


                                       10

<PAGE>


                           PART II: OTHER INFORMATION

Item 1.   Legal Proceedings:

     The Company is in the middle of a  government  investigation  concerning  a
former  product of the Company,  a Rapid HIV Test Kit, and whether the Kits were
manufactured  in accordance with good  manufacturing  practices and received FDA
approvals and  clearances.  The government has  threatened  enforcement  action,
which can range from a  cease-and-desist  order to civil or criminal  penalties.
The new officers felt that because of this  investigation  and the size of their
investment  that it was time to take an active  role in the Company and they and
the  Company  plan to fully  cooperate  with the  government  and work  toward a
settlement  of this  investigation  as well as settling  other  pending  company
litigation.

Item 2.   Changes in Securities:

     None

Item 3.   Defaults Upon Senior Securities:

     None

Item 4.   Submission of Matters to a Vote of Security Holders:

     None

Item 5.   Other Information:

     On  October  7,  2000,  the  Company  announced  the  resignation  of their
president and director James Whidden and  cancellation of his option  agreement.
Mr.  Whidden has returned to Vector  Medical  Technologies,  Inc.,  his previous
employer and a major  customer of SMLX.  The Company also  announced  that Colin
Jones,  former president of the Company who retired this year, has resigned from
the Board. Kenneth H. Robertson,  a Board member, was elected president,  as was
Gerald M. Wochna,  a Board member,  to vice president and general  counsel.  Mr.
Robertson  and Mr.  Wochna  joined the Company from  Robertson & Partners LLC, a
private equity firm that through two of its funds invested $1,200,000 in SMLX in
the summer and fall of 1998.

Item 6.   Exhibits and Reports on Form 8-K:

     (a) Exhibit 27   Financial Data Schedule   Filed herewith electronically

     (b) Reports on Form 8-K: None


                                       11

<PAGE>


                                   SIGNATURES

     Pursuant to the  requirements  of the  Securities and Exchange Act of 1934,
the  Registrant  has duly  cause  this  Report to be signed on its behalf by the
undersigned thereunto duly authorized.

                                           SMLX TECHNOLOGIES, INC.


Date:  November 20, 2000                   /s/    Ken Robertson
                                           Ken Robertson, President

Date:  November 20, 2000                   /s/    Joel Marcus
                                           Joel Marcus, Chief Financial Officer






                                       12